These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis. Rudick RA; Ransohoff RM; Lee JC; Peppler R; Yu M; Mathisen PM; Tuohy VK Neurology; 1998 May; 50(5):1294-300. PubMed ID: 9595977 [TBL] [Abstract][Full Text] [Related]
25. Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosis. Ramgolam VS; Markovic-Plese S Endocr Metab Immune Disord Drug Targets; 2010 Jun; 10(2):161-7. PubMed ID: 20384573 [TBL] [Abstract][Full Text] [Related]
26. Effects of an anti-IL-10 monoclonal antibody on rIFNbeta-1b-mediated immune modulation. Relevance to multiple sclerosis. Porrini AM; De Luca G; Gambi D; Reder AT J Neuroimmunol; 1998 Jan; 81(1-2):109-15. PubMed ID: 9521612 [TBL] [Abstract][Full Text] [Related]
27. Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Duncan DD; Swain SL Eur J Immunol; 1994 Oct; 24(10):2506-14. PubMed ID: 7925578 [TBL] [Abstract][Full Text] [Related]
28. Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis. Bartholomé EJ; Willems F; Crusiaux A; Thielemans K; Schandené L; Goldman M Acta Neurol Belg; 1999 Mar; 99(1):44-52. PubMed ID: 10218092 [TBL] [Abstract][Full Text] [Related]
29. Interferon beta treatment of multiple sclerosis increases serum interleukin-7. Lundström W; Hermanrud C; Sjöstrand M; Brauner S; Wahren-Herlenius M; Olsson T; Karrenbauer V; Hillert J; Fogdell-Hahn A Mult Scler; 2014 Nov; 20(13):1727-36. PubMed ID: 24821684 [TBL] [Abstract][Full Text] [Related]
30. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. Nagai T; Devergne O; Mueller TF; Perkins DL; van Seventer JM; van Seventer GA J Immunol; 2003 Nov; 171(10):5233-43. PubMed ID: 14607924 [TBL] [Abstract][Full Text] [Related]
31. Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: significant modulation of IL-17 and IL-23. Kürtüncü M; Tüzün E; Türkoğlu R; Petek-Balcı B; Içöz S; Pehlivan M; Birişik Ö; Ulusoy C; Shugaiv E; Akman-Demir G; Eraksoy M Cytokine; 2012 Aug; 59(2):400-2. PubMed ID: 22652415 [TBL] [Abstract][Full Text] [Related]
32. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S J Exp Med; 2007 Jan; 204(1):41-7. PubMed ID: 17227914 [TBL] [Abstract][Full Text] [Related]
33. IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis. Lee LF; Axtell R; Tu GH; Logronio K; Dilley J; Yu J; Rickert M; Han B; Evering W; Walker MG; Shi J; de Jong BA; Killestein J; Polman CH; Steinman L; Lin JC Sci Transl Med; 2011 Jul; 3(93):93ra68. PubMed ID: 21795588 [TBL] [Abstract][Full Text] [Related]
34. Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases. de Jong TD; Vosslamber S; Mantel E; de Ridder S; Wesseling JG; van der Pouw Kraan TC; Leurs C; Hegen H; Deisenhammer F; Killestein J; Lundberg IE; Vencovsky J; Nurmohamed MT; van Schaardenburg D; Bultink IE; Voskuyl AE; Pegtel DM; van der Laken CJ; Bijlsma JW; Verweij CL Arthritis Res Ther; 2016 Feb; 18():49. PubMed ID: 26882897 [TBL] [Abstract][Full Text] [Related]
35. T cell response to myelin basic protein before and after treatment with interferon beta in multiple sclerosis. Ristori G; Montesperelli C; Gasperini C; Battistini L; Borsellino G; Buttinelli C; Cannoni S; Perna A; Pozzilli C; Salvetti M J Neuroimmunol; 1999 Sep; 99(1):91-6. PubMed ID: 10496181 [TBL] [Abstract][Full Text] [Related]
36. The mechanism of action of interferon-β in relapsing multiple sclerosis. Kieseier BC CNS Drugs; 2011 Jun; 25(6):491-502. PubMed ID: 21649449 [TBL] [Abstract][Full Text] [Related]
37. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals. Palmer EM; van Seventer GA J Immunol; 1997 Mar; 158(6):2654-62. PubMed ID: 9058798 [TBL] [Abstract][Full Text] [Related]
38. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta. Hussien Y; Sanna A; Söderström M; Link H; Huang YM Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948 [TBL] [Abstract][Full Text] [Related]
39. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis. Ruocco G; Rossi S; Motta C; Macchiarulo G; Barbieri F; De Bardi M; Borsellino G; Finardi A; Grasso MG; Ruggieri S; Gasperini C; Furlan R; Centonze D; Battistini L; Volpe E Clin Sci (Lond); 2015 Aug; 129(4):291-303. PubMed ID: 25700150 [TBL] [Abstract][Full Text] [Related]